1. Home
  2. SPHL vs CDT Comparison

SPHL vs CDT Comparison

Compare SPHL & CDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Springview Holdings Ltd Class A Ordinary Shares

SPHL

Springview Holdings Ltd Class A Ordinary Shares

HOLD

Current Price

$4.14

Market Cap

5.7M

ML Signal

HOLD

CDT

Conduit Pharmaceuticals Inc.

HOLD

Current Price

$0.72

Market Cap

5.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPHL
CDT
Founded
2002
2019
Country
Singapore
United States
Employees
73
4
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.7M
5.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SPHL
CDT
Price
$4.14
$0.72
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.1M
2.6M
Earning Date
05-12-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.35
$0.37
52 Week High
$25.11
$11.00

Technical Indicators

Market Signals
Indicator
SPHL
CDT
Relative Strength Index (RSI) 58.02 33.48
Support Level $3.87 $0.49
Resistance Level $5.38 $1.22
Average True Range (ATR) 1.20 0.28
MACD 0.17 0.03
Stochastic Oscillator 20.81 2.01

Price Performance

Historical Comparison
SPHL
CDT

About SPHL Springview Holdings Ltd Class A Ordinary Shares

Springview Holdings Ltd conducts its operations through its indirect wholly-owned subsidiary, which designs and constructs residential and commercial buildings in Singapore. It also provides four main types of work, including new construction, reconstruction, Additions and Alterations (A&A), and other general contracting services such as renovation and design consultation. The company operates and manages its business as a single segment in the development of construction projects. It derives maximum revenue from its Residential Customers.

About CDT Conduit Pharmaceuticals Inc.

CDT Equity Inc is a data-driven biopharmaceutical development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. It has evolved into a broader, more agile platform that leverages artificial intelligence, solid-form chemistry, and efficient asset repositioning to accelerate the development of novel treatments. The company's pipeline includes candidates that target autoimmune disorders, as well as idiopathic male infertility, oncology, dermatology, rare disease and animal health. It has one operating segment focused on the research and development of clinical assets.

Share on Social Networks: